QIAGEN N.V. Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| AVGO | Broadcom | Outperform |
8
|
$1.24k | $1.21k | 24.71% | 11 | $602.57B |
| JNJ | Johnson & Johnson | Outperform |
9
|
$151.18 | $174.55 | 12.45% | 3 | $348.43B |
| MRK | Merck | Outperform |
2
|
$128.80 | $130.51 | 11.02% | 11 | $327.32B |
| TMO | Thermo Fisher Scientific | Outperform |
10
|
$574.99 | $591.94 | 7.39% | 1 | $217.09B |
| NOVN | Novartis | Hold |
10
|
CHF89.05 | CHF105.00 | 20.85% | 9 | CHF181.70B |
| ROG | Roche Holding | Hold |
16
|
CHF220.60 | CHF307.83 | 20.13% | 9 | CHF178.03B |
| ABT | Abbott Laboratories | Outperform |
9
|
$106.29 | $118.92 | 19.01% | 7 | $183.88B |
| DHR | Danaher | Outperform |
10
|
$246.89 | $260.33 | 9.77% | 4 | $182.67B |
| GE | General Electric | Outperform |
8
|
$159.70 | $144.00 | 12.71% | 3 | $177.13B |
| SIE | Siemens | Outperform |
10
|
175.90€ | 178.14€ | 11.14% | 11 | 137.90€B |
| 6758 | Sony Group | Buy |
6
|
¥13.10k | ¥16.23k | 22.90% | 0 | ¥15.91T |
| GSK | GSK | Outperform |
12
|
£17.05 | £17.30 | 14.37% | 12 | £68.36B |
| MRK | Merck KGaA | Outperform |
18
|
148.95€ | 190.06€ | 22.86% | 4 | 64.76€B |
| BDX | Becton Dickinson and Co | Outperform |
9
|
$233.72 | $284.47 | 18.73% | 8 | $67.78B |
| SHL | Siemens Healthineers | Buy |
8
|
52.10€ | 56.34€ | 15.16% | 9 | 58.13€B |
| A | Agilent Technologies | Outperform |
10
|
$138.69 | $138.82 | 9.24% | 10 | $40.16B |
| PHIA | Koninklijke Philips N.V. | Hold |
18
|
25.25€ | 19.42€ | -8.91% | 9 | 22.83€B |
| ILMN | Illumina | Outperform |
16
|
$124.68 | $159.28 | 20.31% | 9 | $19.60B |
| HOLX | Hologic | Outperform |
8
|
$76.28 | $81.06 | 10.12% | 3 | $17.79B |
| LH | Laboratory Corp of America Hol... | Outperform |
11
|
$201.32 | $241.28 | 19.71% | 9 | $16.98B |
| DGX | Quest Diagnostics | Outperform |
10
|
$137.55 | $141.17 | 5.42% | 8 | $15.35B |
| INF | Informa | Outperform |
15
|
£8.00 | £8.86 | 18.75% | 0 | £10.78B |
| PKI | PerkinElmer | Outperform |
16
|
$102.60 | $121.84 | 20.74% | 1 | $12.66B |
| BIM | bioMérieux | Outperform |
18
|
100.00€ | 105.55€ | 14.00% | 1 | 11.82€B |
| 6869 | Sysmex | Outperform |
18
|
¥7.99k | ¥8.90k | 11.40% | 0 | ¥1.74T |
| EXAS | Exact Sciences | Buy |
8
|
$60.01 | $90.32 | 47.66% | 7 | $10.91B |
| SN. | Smith & Nephew | Outperform |
18
|
£9.77 | £16.09 | 67.96% | 10 | £8.54B |
| NTRA | Natera | Outperform |
7
|
$94.15 | $74.41 | 9.40% | 8 | $11.35B |
| TECH | Bio-Techne Corp | Buy |
16
|
$73.46 | $100.78 | 8.90% | 2 | $9.94B |
| BIO | Bio-Rad Laboratories Inc | Buy |
16
|
$274.06 | $536.80 | 55.70% | 1 | $7.74B |
| GRF | Grifols | Outperform |
18
|
8.65€ | 18.48€ | 119.65% | 3 | 5.19€B |
| TXG | 10x Genomics | Outperform |
6
|
$26.92 | $58.14 | 93.16% | 2 | $3.51B |
| QDEL | Quidel Corp | Hold |
16
|
$39.68 | $121.00 | 34.07% | 6 | $2.71B |
| 300676 | BGI Genomics | - |
17
|
¥41.13 | ¥0.00 | -100.00% | 0 | ¥15.61B |
| GH | Guardant Health | Buy |
6
|
$18.26 | $43.00 | 140.96% | 2 | $2.19B |
| PACB | Pacific Biosciences of Califor... | Outperform |
9
|
$1.69 | $12.67 | 107.10% | 4 | $449.37M |
| NEO | NeoGenomics | Outperform |
8
|
$13.96 | $20.09 | 39.68% | 9 | $1.78B |
| 4974 | Takara Bio | Outperform |
16
|
¥1.22k | ¥0.00 | 31.58% | 0 | ¥276.96B |
| MYGN | Myriad Genetics | Hold |
6
|
$19.47 | $22.08 | 28.40% | 8 | $1.77B |
| VCYT | Veracyte | Outperform |
11
|
$20.13 | $32.17 | 61.45% | 4 | $1.50B |
| VIVO | Meridian Bioscience | - |
18
|
$0.03 | $34.00 | -100.00% | 0 | $1.46B |
| OPK | OPKO Health | Outperform |
8
|
$1.01 | $6.70 | 296.04% | 0 | $1.18B |
| QTRX | Quanterix | Outperform |
11
|
$16.49 | $32.00 | 94.06% | 0 | $616.54M |
| LAB | Standard BioTools | Buy |
11
|
$2.54 | $4.00 | 37.80% | 1 | $948.50M |
| CDNA | CareDx, Inc | Outperform |
9
|
$9.18 | $11.80 | 36.17% | 1 | $403.58M |
| ATOS | Atossa Genetics Inc | Buy |
5
|
$1.51 | $4.83 | 164.90% | 0 | $219.28M |
| AGL | ANGLE | Buy |
8
|
£0.14 | £0.97 | 392.86% | 0 | £35.81M |
| PEB | Pacific Edge | Hold |
11
|
$0.09 | $0.14 | 55.56% | 2 | $75.45M |
| 8YY | Biolidics | - |
-13
|
$0.01 | $0.00 | -100.00% | 0 | $53.09M |
| CODX | Co-Diagnostics | Hold |
10
|
$1.16 | $3.00 | 115.52% | 1 | $35.47M |
| TTOO | T2 Biosystems | - |
6
|
$3.36 | $8.68 | -10.71% | 0 | $24.09M |
| XGN | Exagen | Buy |
6
|
$1.39 | $5.75 | 259.71% | 2 | $23.61M |
| AXDX | Accelerate Diagnostics | Buy |
8
|
$0.88 | $5.00 | -100.00% | 1 | $21.49M |
| LXXG.Q | LexaGene Holdings | - |
4
|
$0.11 | $0.75 | -100.00% | 0 | $11.34M |
| NSTG | NanoString Technologies | - |
7
|
$0.26 | $5.02 | -100.00% | 4 | $9.62M |
| PRPO | Precipio | - |
0
|
$5.75 | $19.00 | -100.00% | 1 | $9.44M |
| GTHP | Guided Therapeutics | - |
0
|
$0.14 | $0.09B | -100.00% | 0 | $7.35M |
| BIOC.Q | Biocept | Hold |
-16
|
$0.00 | $8.00 | 0.00% | 0 | $0.13M |
| MTST | MetaStat | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.00M |
| HTGM.Q | HTG Molecular Diagnostics | - |
6
|
$0.00 | $6.00 | 0.00% | 1 | $0.00M |